The current role of neoadjuvant/adjuvant/chemoprevention therapy in partial hepatectomy for hepatocellular carcinoma:a systematic review |
| |
| Authors: | Wan-Yee Lau Eric CHLai Stephanie HYLau Hong Kong China State Key Laboratory for Diagnosis Treatment of Infectious Diseases First Affiliated Hospital Zhejiang University School of Medicine Hangzhou China |
| |
| Institution: | Wan-Yee Lau,Eric C.H.Lai , Stephanie H.Y.Lau Hong Kong,China State Key Laboratory for Diagnosis , Treatment of Infectious Diseases,First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China |
| |
| Abstract: | BACKGROUND:Following curative treatment for hepato-cellular carcinoma(HCC),50%-90% of postoperative death is due to recurrent disease.Intra-hepatic recurrence is frequently the only site of recurrence.Thus,any neoadjuvant or adjuvant therapy,which can decrease or delay the incidence of intra-hepatic recurrence,or any cancer chemoprevention which can prevent a new HCC from developing in the liver remnant,will improve the results of liver resection.This article systematically reviewed the current evidence of ... |
| |
| Keywords: | hepatocellular carcinoma hepatectomy adjuvant therapy neoadjuvant therapy therapeutic embolization |
| 本文献已被 CNKI 等数据库收录！ |
|
